• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激响应型化学在控制药物释放领域的应用。

Stimulus-cleavable chemistry in the field of controlled drug delivery.

机构信息

Frontiers Science Center for Flexible Electronics, Xi'an Institute of Flexible Electronics (IFE) and Xi'an Institute of Biomedical Materials & Engineering, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an 710072, China.

Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, Victoria 3168, Australia.

出版信息

Chem Soc Rev. 2021 Apr 26;50(8):4872-4931. doi: 10.1039/d0cs01061h.

DOI:10.1039/d0cs01061h
PMID:33734247
Abstract

Stimulus-cleavable nanoscale drug delivery systems are receiving significant attention owing to their capability of achieving exquisite control over drug release via the exposure to specific stimuli. Central to the construction of such systems is the integration of cleavable linkers showing susceptibility to one stimulus or several stimuli with drugs, prodrugs or fluorogenic probes on the one hand, and nanocarriers on the other hand. This review summarises recent advances in stimulus-cleavable linkers from various research areas and the corresponding mechanisms of linker cleavage and biological applications. The feasibility of extending their applications to the majority of nanoscale drug carriers including nanomaterials, polymers and antibodies are further highlighted and discussed. This review also provides general design guidelines to incorporate stimulus-cleavable linkers into nanocarrier-based drug delivery systems, which will hopefully spark new ideas and applications.

摘要

刺激响应型纳米药物递送系统因其能够通过特定刺激实现药物释放的精确控制而受到广泛关注。这类系统的构建核心是将对一种或多种刺激敏感的可裂解连接子与药物、前药或荧光探针一方面,以及与纳米载体另一方面集成在一起。本综述总结了来自不同研究领域的刺激响应型连接子的最新进展,以及相应的连接子断裂机制和生物学应用。还进一步强调和讨论了将其应用扩展到包括纳米材料、聚合物和抗体在内的大多数纳米药物载体的可行性。本文还提供了将刺激响应型连接子纳入基于纳米载体的药物递送系统的一般设计准则,希望能激发新的思路和应用。

相似文献

1
Stimulus-cleavable chemistry in the field of controlled drug delivery.刺激响应型化学在控制药物释放领域的应用。
Chem Soc Rev. 2021 Apr 26;50(8):4872-4931. doi: 10.1039/d0cs01061h.
2
[Reactive oxygen species stimuli-responsive nanocarriers].[活性氧物种刺激响应性纳米载体]
Se Pu. 2021 Feb;39(2):118-124. doi: 10.3724/SP.J.1123.2020.11014.
3
pH-responsive micro- and nanocarrier systems.pH 响应型微纳米载体系统。
Angew Chem Int Ed Engl. 2014 Jan 3;53(1):49-51. doi: 10.1002/anie.201308619. Epub 2013 Dec 4.
4
Stimuli-Responsive Boron-Based Materials in Drug Delivery.刺激响应型硼基药物递送材料
Int J Mol Sci. 2023 Feb 1;24(3):2757. doi: 10.3390/ijms24032757.
5
Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy.具有刺激响应性连接子的多孔硅纳米载体用于有效的癌症治疗。
Adv Healthc Mater. 2022 Jun;11(12):e2200076. doi: 10.1002/adhm.202200076. Epub 2022 Apr 3.
6
Tailored Drug Delivery Platforms: Stimulus-Responsive Core-Shell Structured Nanocarriers.定制药物传递平台:刺激响应型核壳结构纳米载体。
Adv Healthc Mater. 2024 Jan;13(1):e2301726. doi: 10.1002/adhm.202301726. Epub 2023 Sep 20.
7
Disulfide-Based Self-Immolative Linkers and Functional Bioconjugates for Biological Applications.基于二硫键的自毁连接剂及用于生物应用的功能生物缀合物。
Macromol Rapid Commun. 2020 Jan;41(1):e1900531. doi: 10.1002/marc.201900531. Epub 2019 Nov 22.
8
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.刺激响应型聚合物纳米载体用于活性化合物的控制传递:概念与应用。
Adv Drug Deliv Rev. 2012 Jun 15;64(9):866-84. doi: 10.1016/j.addr.2012.01.020. Epub 2012 Feb 11.
9
Dendronized Systems for the Delivery of Chemotherapeutics.树状系统用于递送化疗药物。
Adv Cancer Res. 2018;139:85-120. doi: 10.1016/bs.acr.2018.04.003. Epub 2018 May 18.
10
Smart synthetic polymer nanocarriers for controlled and site-specific drug delivery.用于可控和位点特异性药物递送的智能合成聚合物纳米载体。
Curr Top Med Chem. 2015;15(15):1424-90. doi: 10.2174/1568026615666150414115852.

引用本文的文献

1
Recent progress in stimuli-activable metallo-prodrugs for cancer therapy.用于癌症治疗的刺激激活型金属前药的最新进展。
Smart Mol. 2024 Aug 29;2(3):e20240030. doi: 10.1002/smo.20240030. eCollection 2024 Sep.
2
Advancing Antibody-Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers.推进抗体药物偶联物:乳腺癌和胰腺癌的精准肿瘤学方法
Cancers (Basel). 2025 May 27;17(11):1792. doi: 10.3390/cancers17111792.
3
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.
利用模块化白蛋白搭载纳米抗体-STING激动剂偶联物增强癌症免疫疗法。
Nat Biomed Eng. 2025 Jun 11. doi: 10.1038/s41551-025-01400-0.
4
Blueprints for Better Drugs: The Structural Revolution in Nanomedicine.更好药物的蓝图:纳米医学的结构革命
ACS Nano. 2025 May 27;19(20):18889-18901. doi: 10.1021/acsnano.5c06380. Epub 2025 May 13.
5
Unveiling research hotspots: a bibliometric study on macrophages in musculoskeletal diseases.揭示研究热点:肌肉骨骼疾病中巨噬细胞的文献计量学研究
Front Immunol. 2025 Apr 28;16:1519321. doi: 10.3389/fimmu.2025.1519321. eCollection 2025.
6
Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer.用于癌症光动力治疗的活性氧(ROS)响应型药物递送系统的最新进展
Acta Pharm Sin B. 2024 Dec;14(12):5106-5131. doi: 10.1016/j.apsb.2024.10.015. Epub 2024 Nov 2.
7
A dual-locked cyclopeptide-siRNA conjugate for tumor-specific gene silencing.一种用于肿瘤特异性基因沉默的双锁环肽-siRNA缀合物。
RSC Chem Biol. 2024 Nov 25;6(1):73-80. doi: 10.1039/d4cb00247d. eCollection 2025 Jan 2.
8
Light-Activated Anti-Vascular Combination Therapy against Choroidal Neovascularization.光激活抗血管联合疗法治疗脉络膜新生血管。
Adv Sci (Weinh). 2024 Oct;11(40):e2404218. doi: 10.1002/advs.202404218. Epub 2024 Aug 29.
9
Stimuli-responsive linkers and their application in molecular imaging.刺激响应性连接体及其在分子成像中的应用。
Exploration (Beijing). 2024 Jan 18;4(4):20230027. doi: 10.1002/EXP.20230027. eCollection 2024 Aug.
10
Functionalizing Thiosemicarbazones for Covalent Conjugation.用于共价共轭的硫代氨基脲功能化
Molecules. 2024 Aug 3;29(15):3680. doi: 10.3390/molecules29153680.